Immuneering Corporation (IMRX) Statistics & Valuation Metrics - Stocknear

Immuneering Corporation

NASDAQ: IMRX · Real-Time Price · USD
8.08
0.08 (1.00%)
At close: Sep 26, 2025, 3:59 PM
8.05
-0.37%
After-hours: Sep 26, 2025, 07:51 PM EDT

Immuneering Statistics

Share Statistics

Immuneering has 36.3M shares outstanding. The number of shares has increased by 21.35% in one year.

36.3M
21.35%
0.27%
12.66%
28.61M
309
0.02%

Short Selling Information

The latest short interest is 2.96M, so 7.12% of the outstanding shares have been sold short.

2.96M
7.12%
8.95%
2.69

Valuation Ratios

The PE ratio is -1.08 and the forward PE ratio is -4.88. Immuneering's PEG ratio is -0.13.

-1.08
-4.88
0
13.8
1.59
-1.2
-0.13
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Immuneering.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.1.

5.28
5.28
0.1
-0.07
-0.08
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.13M
54
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 203.76% in the last 52 weeks. The beta is 0.43, so Immuneering's price volatility has been higher than the market average.

0.43
203.76%
5.4
2.83
58.33
1,320,361

Income Statement

n/a
-713.45K
-64.07M
-61.04M
-63.69M
-64.07M
-2.04
Full Income Statement

Balance Sheet

The company has 36.15M in cash and 4.16M in debt, giving a net cash position of 31.98M.

36.15M
4.16M
31.98M
-224.29M
40.06M
20.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -55M and capital expenditures -84.88K, giving a free cash flow of -55.08M.

-55M
-84.88K
-55.08M
-1.84
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

IMRX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for IMRX is $15.5, which is 91.8% higher than the current price. The consensus rating is "Strong Buy".

$15.5
91.8%
Strong Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

2.56
2